ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,651,779 | -75.1% | 79,260 | -71.4% | 0.01% | -75.0% |
| Q2 2023 | $6,638,845 | -47.9% | 277,196 | -59.0% | 0.02% | -55.6% |
| Q1 2023 | $12,737,225 | -16.3% | 676,792 | -29.2% | 0.04% | -18.2% |
| Q4 2022 | $15,214,553 | +3914.4% | 955,688 | +4022.0% | 0.06% | +2650.0% |
| Q3 2022 | $379,000 | -19.4% | 23,185 | +19.3% | 0.00% | 0.0% |
| Q1 2022 | $470,000 | -82.5% | 19,436 | -61.2% | 0.00% | -83.3% |
| Q4 2020 | $2,680,000 | +9.7% | 50,129 | -15.4% | 0.01% | +20.0% |
| Q3 2020 | $2,444,000 | -56.3% | 59,260 | -48.7% | 0.01% | -64.3% |
| Q2 2020 | $5,594,000 | +167.0% | 115,420 | +132.8% | 0.03% | +100.0% |
| Q1 2020 | $2,095,000 | -43.9% | 49,585 | -43.2% | 0.01% | +16.7% |
| Q4 2019 | $3,735,000 | +188.6% | 87,317 | +81.1% | 0.01% | +140.0% |
| Q1 2019 | $1,294,000 | +60.5% | 48,215 | -3.3% | 0.01% | +25.0% |
| Q4 2018 | $806,000 | +467.6% | 49,861 | +689.7% | 0.00% | +300.0% |
| Q1 2018 | $142,000 | – | 6,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |